news

Clifford Chance has advised Beijing-based Sunshine Insurance Group on its HK$6.7 billion ($861 million) IPO on the Hong Kong Stock Exchange, with Linklaters and King & Wood Mallesons acting for the underwriters.

The IPO is the second-largest in Hong Kong in 2022, after Chinese battery supplier CALB raised $1.3 billion in late September. Clifford Chance advised the sponsors of that deal.

Reuters said that 2022 is shaping up to be the worst year for IPOs in Hong Kong since 2012, due to rising interest rates and global financial market volatility.

The Clifford Chance team was led by China co-managing partner Tim Wang and partners Fang Liu in Hong Kong and Tianning Xiang in Beijing.

Meanwhile, the Linklaters team was led by partners Christopher Yip and Lipton Li.

The underwriters included Huatai Financial Holdings (Hong Kong) and China International Capital Corporation Hong Kong Securities.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

CC, Paul Hastings lead on CR Beverages’ HK IPO

by Charlie Wu 吴卓言 |

Clifford Chance and Jingtian & Gongcheng are advising China Resources Beverages, the beverage division of the state-owned China Resources Enterprise, on its upcoming Hong Kong IPO, which is expected to raise up to $1 billion. Paul Hastings and Zhong Lun Law Firm are acting for the joint sponsors.

Haiwen, CC advise on China TCM's $2 bln take-private deal

Sinopharm Group, an investment consortium led by Sinopharm Group, and China Traditional Chinese Medicine Holdings (China TCM) recently announced a take-private deal for the Hong Kong-listed China TCM through a scheme of arrangement.

CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO

by Charlie Wu 吴卓言 |

Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.